RE104 Safety and Efficacy Study in Postpartum Depression

Recruiting

Phase 2

RE104 Safety and Efficacy Study in Postpartum DepressionRE104 Safety and Efficacy Study in Postpartum Depression

Sponsor:

Reunion Neuroscience Inc

Code:

NCT06342310

Conditions

Postpartum Depression

Eligibility Criteria

Sex: Female

Age: 18 - 45

Healthy Volunteers: Not accepted

Interventions

RE104 for Injection

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Reunion Neuroscience Inc on 2025-03-25.